Investors will be watching as results continue to mature, but shares meanwhile of Redwood City, Calif.-based Coherus Oncology Inc. (NASDAQ:CHRS) closed Oct. 29 at 90 cents, down 26…
Investors will be watching as results continue to mature, but shares meanwhile of Redwood City, Calif.-based Coherus Oncology Inc. (NASDAQ:CHRS) closed Oct. 29 at 90 cents, down 26 cents, or 23%, after interim phase Ib data were made public from the Tregcheck program with tagmokitug (tagmo), a…
Source disclosure
This is a source-linked briefing. Read the original report from Bioworld .